Profility Inc, a cloud-based, enterprise-grade platform, offers a comprehensive suite of post-acute care connectivity solutions and tools that are simple to implement and do not necessitate extensive integration with existing systems and software products. The platform uses multiple existing big data sources and predictive analytics technology to create personalized care planning profiles that can be used to support post-acute care decision making across all aspects of care delivery . The fund is led by managers with extensive business experience in the Health, MedTech, Entrepreneurship, and Capital industries. Existing investors and founders were also in attendance.
The company announced the addition of Yaron Itzhari, Co-Founder and Managing Partner of Valitas VC, to its Board of Directors.
Yaron Itzhari, Co-Founder and Managing Partner of Valitas, is in charge of the venture capital GTM investment strategy and vision. Prior to founding Valitas VC, he was the CEO of Medtronic Israel. Itzhari has over 20 years of experience in the pharmaceutical and medical technology industries. Itzhari established and chaired the Medtech Association in Israel.
By optimizing decisions and transitions within a healthcare ecosystem, PROFILITY provides technology that enables truly personalized care planning. Profility creates a transition profile to support all critical decision points in the discharge process by combining EMR summary techniques with profiling predictive analytics technology.
The transition profile structures all of the patient’s UNIQUE CHARACTERISTICS, matches clusters of near-clones, and generates sophisticated estimates of the patient’s potential and risks.
